

Your fight against
head and neck cancer
may continue here
OPDIVO is an FDA-approved immunotherapy option to treat head and neck squamous cell carcinoma that has returned or spread after previous treatment
Your fight against
head and neck cancer
may continue here
OPDIVO is an FDA-approved immunotherapy option to treat head and neck squamous cell carcinoma that has returned or spread after previous treatment
Actor portrayals.
OPDIVO is a treatment option for certain adults with squamous cell carcinoma of the head and neck (SCCHN) that has returned or spread after previous treatment
You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO
OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO and OPDIVO Qvantig will not work for everyone. Individual results may vary.
We have answers about getting treatment, monitoring, and more